Suppr超能文献

供体器官内血管嵌合体的生成。

Generation of vascular chimerism within donor organs.

机构信息

Laboratory for Organ Bioengineering, Rabin Medical Center, Petah Tikva, Israel.

Felsenstien Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.

出版信息

Sci Rep. 2021 Jun 28;11(1):13437. doi: 10.1038/s41598-021-92823-7.

Abstract

Whole organ perfusion decellularization has been proposed as a promising method to generate non-immunogenic organs from allogeneic and xenogeneic donors. However, the ability to recellularize organ scaffolds with multiple patient-specific cells in a spatially controlled manner remains challenging. Here, we propose that replacing donor endothelial cells alone, while keeping the rest of the organ viable and functional, is more technically feasible, and may offer a significant shortcut in the efforts to engineer transplantable organs. Vascular decellularization was achieved ex vivo, under controlled machine perfusion conditions, in various rat and porcine organs, including the kidneys, liver, lungs, heart, aorta, hind limbs, and pancreas. In addition, vascular decellularization of selected organs was performed in situ, within the donor body, achieving better control over the perfusion process. Human placenta-derived endothelial progenitor cells (EPCs) were used as immunologically-acceptable human cells to repopulate the luminal surface of de-endothelialized aorta (in vitro), kidneys, lungs and hind limbs (ex vivo). This study provides evidence that artificially generating vascular chimerism is feasible and could potentially pave the way for crossing the immunological barrier to xenotransplantation, as well as reducing the immunological burden of allogeneic grafts.

摘要

整体器官灌注去细胞化已被提议作为一种有前途的方法,可从同种异体和异种供体中产生非免疫原性器官。然而,以空间控制的方式用多种患者特异性细胞再细胞化器官支架的能力仍然具有挑战性。在这里,我们提出,单独替换供体内皮细胞,同时保持器官的其余部分存活和功能,在技术上更可行,并且可能在工程化可移植器官的努力中提供显著的捷径。在各种大鼠和猪器官(包括肾脏、肝脏、肺、心脏、主动脉、后肢和胰腺)中,在受控机器灌注条件下进行了体外血管去细胞化。此外,在供体体内原位进行了选定器官的血管去细胞化,从而更好地控制了灌注过程。用人胎盘衍生的内皮祖细胞(EPC)作为免疫上可接受的人细胞,在去细胞化的主动脉(体外)、肾脏、肺和后肢(体外)的内腔表面再殖。这项研究提供了证据,表明人工产生血管嵌合体是可行的,并且可能为克服异种移植的免疫障碍以及减少同种异体移植物的免疫负担铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c56/8238957/f63439e20196/41598_2021_92823_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验